Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2005
11/10/2005CA2686815A1 Therapeutic antimicrobial compositions and methods
11/10/2005CA2606443A1 Antimicrobial composition
11/10/2005CA2595116A1 Oral formulation for delivery of poorly absorbed drugs
11/10/2005CA2582265A1 Buccal, polar and non-polar sprays containing propofol
11/10/2005CA2579767A1 Oral pharmaceutical composition in timed-release particle form and fast-disintegrating tablets containing this composition
11/10/2005CA2565941A1 Improved nsaid composition
11/10/2005CA2565626A1 Compositions for progeny gender control
11/10/2005CA2565382A1 Use of a viscoelastic composition for treating increased intraocular pressure
11/10/2005CA2565134A1 Novel oral formulations of ospemifene
11/10/2005CA2564982A1 Pegylated nanoparticles
11/10/2005CA2564974A1 Immune response stimulating composition comprising methyl vinyl ether-maleic anhydride copolymer-based nanoparticles
11/10/2005CA2564877A1 Formulation comprising histone deacetylase inhibitors
11/10/2005CA2564234A1 Dermally applicable liquid formulations for controlling parasitic arthropods on animals
11/10/2005CA2564134A1 Antifungal drug delivery
11/10/2005CA2563985A1 Improved pullulan capsules
11/10/2005CA2563957A1 Low molecular weight polylactic acid polymers
11/10/2005CA2563830A1 Transdermal steroid formulation
11/10/2005CA2563829A1 Process for the selective increase of a release rate of an active material from a pharmaceutical composition
11/10/2005CA2563760A1 Pharmaceutical compositions comprising glycopyrrolate
11/10/2005CA2563593A1 Paper tissue with high lotion transferability
11/10/2005CA2563409A1 Dosage form having polymorphic stability
11/10/2005CA2562919A1 Aqueous solutions comprising prednisolone and a cyclodextrin derivative
11/10/2005CA2562741A1 Active drug delivery in the gastrointestinal tract
11/10/2005CA2562585A1 Dpi formulation containing sulfoalkyl ether cyclodextrin
11/10/2005CA2562527A1 Polymer conjugate releasable under mild thiolytic conditions
11/10/2005CA2562379A1 Veterinary meloxicam formulations suitable for intramammary treatment ofinflammatory disorders in mammals
11/10/2005CA2560167A1 Statins for the treatment of ocular hypertension and glaucoma
11/10/2005CA2560165A1 Solid pharmaceutical form comprising an ltb4 antagonist
11/09/2005EP1593395A2 Gas filled microspheres as magnetic resonance imaging contrast agents
11/09/2005EP1593387A1 Compositions for the treatment of impaired interpersonal and behavioral disorders
11/09/2005EP1593384A2 Compositions for treatment of sexual dysfunction
11/09/2005EP1593382A1 Use of probiotic lactic bacteria for balancing the skin's immune system
11/09/2005EP1593380A2 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits
11/09/2005EP1593377A1 Crosslinkable macromers bearing initiator groups
11/09/2005EP1593376A1 Improved pullulan capsules
11/09/2005EP1593375A1 Body cavity washer, device for washing body cavity and method of washing body cavity
11/09/2005EP1593374A1 Remote control release of encapsulated material
11/09/2005EP1593311A1 Method for preparing food or animal feed
11/09/2005EP1593127A2 Radiation protection by gamma-tocotrienol
11/09/2005EP1593081A2 Method and system for medical device connectivity
11/09/2005EP1593080A2 Wireless medical data communication system and method
11/09/2005EP1593079A2 System and method for verifying medical device operational parameters
11/09/2005EP1593078A2 Medical data communication notification and messaging system and method
11/09/2005EP1592760A2 Solid dispersion compositions
11/09/2005EP1592724A2 Preparation of polyphosphazene microspheres
11/09/2005EP1592694A2 Salt of a sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
11/09/2005EP1592488A2 Method and apparatus for producing particles via supercritical fluid processing
11/09/2005EP1592464A2 Method of treating cognitive decline due to sleep deprivation and stress
11/09/2005EP1592452A2 Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology
11/09/2005EP1592451A1 Stable dispersion of solid particles comprising a water-insoluble pyrazine compound
11/09/2005EP1592450A2 Use of a volatile liquid at atmospheric pressure and ambient temperature for the production of pharmaceutical or biological compositions
11/09/2005EP1592447A1 Devices and compositions containing boron and silicon for use in neutron capture therapy
11/09/2005EP1592443A1 Improved anthrax vaccines and delivery methods
11/09/2005EP1592435A1 Ophthalmic formulation for the prevention and treatment of ocular conditions
11/09/2005EP1592430A2 Treatment of benign prostatic hyperplasia using energolytic agents
11/09/2005EP1592420A1 Clindamycin phosphate foam
11/09/2005EP1592414A1 Injectable liquid formulation of paracetamol
11/09/2005EP1592411A2 Controlled release of highly soluble agents
11/09/2005EP1592410A1 Methods and dosage forms with modified layer geometry
11/09/2005EP1592409A2 Use of edible acid in fast-dispersing pharmaceutical solid dosage forms
11/09/2005EP1592408A2 Sustained release device and method for ocular delivery of adrenergic agents
11/09/2005EP1592407A2 Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
11/09/2005EP1592406A2 Lipophilic compositions
11/09/2005EP1592405A1 Composition for chemoembolotherapy of solid tumors
11/09/2005EP1592404A1 Aqueous dispersion comprising stable nanoparticles of a water-insoluble pyrrole carboxamide and an excipient like middle chain triglycerides
11/09/2005EP1592403A1 Aqueous dispersion comprising stable nanoparticles of a water-insoluble thiazole derivative and excipients like middle chain triglycerides
11/09/2005EP1592402A2 Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
11/09/2005EP1592401A2 Process for modifying drug crystal formation
11/09/2005EP1592400A2 Suspension vehicle for coated drug particles
11/09/2005EP1592399A1 Solid amorphous mixtures, processes for the preparation thereof and pharmaceutical compositions containing the same
11/09/2005EP1592384A2 Cop 1 for treatment of inflammatory bowel diseases
11/09/2005EP1592373A2 Freeze-dried fibrin matrices and methods for preparation thereof
11/09/2005EP1480990B1 Compounds for use as surfactants
11/09/2005EP1418891B1 Anaesthetic formulations of propofol
11/09/2005EP1373472A4 Methods and gel compositions for encapsulating living cells and organic molecules
11/09/2005EP1365748B1 Particulate composition of eletriptan hydrobromide showing a sigmoidal pattern of controlled release
11/09/2005EP1338275A4 Pharmaceutical composition, the use thereof and method for producing said composition
11/09/2005EP1212069B1 Improved topical compositions containing extracellular products of probiotic bacteria and uses thereof
11/09/2005EP1204321B1 Super-active porcine growth hormone releasing hormone analog
11/09/2005EP1189605B1 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof
11/09/2005EP1173218B1 Mucosally adhesive compositions for the treatment of disorders of the oesophagus and their use.
11/09/2005EP1149066B1 Method of preparing alkylated salicylamides
11/09/2005EP1140029B1 Preparation of microparticles having a selected release profile
11/09/2005EP1131055B1 Treatment set containing lungsurfactant compositions
11/09/2005EP1130964B1 Therapeutic anti-fungal nail preparation
11/09/2005EP1087747B1 Foaming composition for hair care
11/09/2005EP1030653B1 Dinitroaniline liposomal formulations and processes for their preparation
11/09/2005EP1014941A4 Hot-melt extrudable pharmaceutical formulation
11/09/2005EP1001744B1 MICROPARTICLES BASED ON HYBRID POLYMERIC MATERIALS FOR CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE MOLECULES, A PROCESS FOR PREPARING THE SAME AND THEIR USES FOR $i(IN VIVO) AND $i(IN VITRO) THERAPY, PROPHYLAXIS AND DIAGNOSTICS
11/09/2005EP0975227B1 Topical use of probiotic bacillus spores to prevent or control microbial infections
11/09/2005EP0971745B1 Gel delivery vehicles for anticellular proliferative agents
11/09/2005EP0960192B1 Synthetic polynucleotides
11/09/2005EP0716615B1 Low flux transdermal potent drug delivery system
11/09/2005CN2738800Y Medicinal dressing pad for external application
11/09/2005CN2738799Y External-use plaster medicinal substrate
11/09/2005CN2738798Y Multi purpose plaster
11/09/2005CN2738797Y Scar diminishing plaster
11/09/2005CN1695184A Read/write device for optical memory and method therefore
11/09/2005CN1694938A Spraying composition
11/09/2005CN1694867A Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same
1 ... 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 ... 2991